BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Pharm Country

  GNC Encourages Stockholders To Vote In Connection With Hayao Investment

  GNC Holdings Inc. reminded stockholders to vote in advance of the Special Meeting of Stockholders scheduled to reconvene on Wednesday, May 9, 2018 (the “Special Meeting”).

  May 2, 2018

   · 

  9 min read
• FDA

  REGENXBIO Receives FDA Fast Track Designation for RGX-121 Gene Therapy for the Treatment of Mucopolysaccharidosis Type II

  REGENXBIO Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for RGX-121.

  May 2, 2018

   · 

  8 min read
• Business

  HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board

  HeartSciences announced that Peter W. Macfarlane has joined its board of clinical advisors.

  May 2, 2018

   · 

  3 min read
• Business

  Anika Reports First Quarter 2018 Financial Results

  Anika Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2018, along with business progress in the period.

  May 2, 2018

   · 

  12 min read
• Business

  QIAGEN Reports Results for First Quarter 2018

  QIAGEN N.V. announced results of operations for the first quarter.

  May 2, 2018

   · 

  1 min read
• Business

  Exelixis Announces First Quarter 2018 Financial Results and Provides Corporate Update

  Exelixis, Inc. reported financial results for the first quarter of 2018.

  May 2, 2018

   · 

  20 min read
• Business

  bluebird bio Reports First Quarter 2018 Financial Results and Highlights Operational Progress

  bluebird bio, Inc. reported financial results and business highlights for the first quarter ended March 31, 2018.

  May 2, 2018

   · 

  10 min read
• Business

  Endologix Appoints John Onopchenko as Chief Executive Officer

  Endologix, Inc. announced that it has appointed John Onopchenko as the Company’s Chief Executive Officer, effective immediately.

  May 2, 2018

   · 

  5 min read
• Job Trends

  NOVO Med Spa Offers GAINSWave® in the Dallas-Fort Worth Area

  Dr. Jerry Lewis, is pleased to announce he now offers GAINSWave at his two locations outside of Dallas!

  May 2, 2018

   · 

  2 min read
• Business

  Express Scripts Announces 2018 First Quarter Results

  Express Scripts Holding Company announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share.

  May 2, 2018

   · 

  59 min read